Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Randomized Double-Blind Placebo-Controlled Study of Dupilumab in Bilateral Nasal Polyposis with Chronic Sinusitis Symptoms
2013-001803-35Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing Dupilumab with Placebo (2 arms). Primary endpoint: Change from baseline in endoscopic Nasal Polyp Score (NPS). Started May 2013; status: completed.
02
Drugs
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on 2013-001803-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001803-35.